Harmony Biosciences Holdings Inc (HRMY) Return on Assets ROA from the third quarter of 2026 to third quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Harmony Biosciences Holdings inc   (NASDAQ: HRMY)


Harmony Biosciences Holdings Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Harmony Biosciences Holdings Inc 's ROA in the third quarter of 2026?
Harmony Biosciences Holdings inc achieved a return on average assets (ROA) of 13.27 % in its third quarter of 2026, which is below Harmony Biosciences Holdings Inc 's average return on assets, which stands at 16.8%.

ROA decreased relative to the period ending Jun 30 2026, due to the decline in net income.

However, within the Healthcare sector 66 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2026 from 461 to 495.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Total Assets Change 21.36 % 23.92 % 20.49 % 56.87 % 62.26 %
Y / Y Net Income Change -5.25 % 89.64 % -28.69 % -54.55 % 10.35 %
Net Income (TTM) in million 179 181 146 159 186
Return On Assets (TTM) 13.27 % 14.15 % 11.99 % 13.67 % 17.76 %
HRMY's Total Ranking # 495 # 461 # 291 # 276 # 323
Total Assets (TTM) in million 1,466 1,373 1,272 1,272 1,208
Seq. Total Assets Change 6.79 % 7.96 % 0.02 % 5.25 % 9.04 %
Seq. Net Income Change -36.11 % 132.18 % 44.48 % -55.79 % 27.88 %

HRMY's 5 Years Annual ROA >> Back to HRMY Management Effectiveness >> Compare HRMY ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 29
Sector # 67
Overall # 381

Return On Assets Statistics
High Average Low
31.75 %
16.8 %
3.08 %
(Dec 31 2022)   (Sep 30 2021)





Financial Statements
Harmony Biosciences Holdings Inc 's Assets $ 1,466 million HRMY's Balance sheet
Harmony Biosciences Holdings Inc 's Income $ 48 million Quarterly HRMY's Income Statement
HRMY's Income by Division See HRMY's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 70.08 % -0.13 % 20.19 % 55.82 % 1.49 %
Total Assets in million 1,379 811 812 675 433
Y / Y Net Income Change 9.07 % 12.91 % -28.99 % 424.52 % -
Net Income in million 159 145 129 181 35
Annual Return On Assets 11.51 % 17.95 % 15.87 % 26.87 % 7.98 %

HRMY's 5 Years Annual ROA >> Back to HRMY Management Effectiveness >> Compare HRMY ROA to its Competitors



Comment on HRMY's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA deteriorated to 11.51 %, despite annual net income growth of 9.07 % to $158.69 million, from $145.49 million a year ago, as HRMY's assets increase to $1,378.76 million, by 9.07 %.


More Return On Assets Ratios
HRMY's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
HRMY's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for HRMY's Competitors
Subscribers only: Roa for Harmony Biosciences Holdings Inc 's Suppliers
Subscribers only: Return On Assets for HRMY's Customers

You may also want to know
HRMY's Roi HRMY's Inventory Turnover Ratio HRMY's Growth Rates HRMY's Dividend Comparisons
HRMY's Profitability Ratios HRMY's Asset Turnover Ratio HRMY's Dividend Growth
HRMY's Roe HRMY's Valuation Ratios HRMY's Financial Strength Ratios HRMY's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector ROA
Indivior Pharmaceuticals Inc   36.35 %
Rallybio Corporation  34.55 %
Idexx Laboratories Inc  34.05 %
Zevra Therapeutics Inc   26.33 %
Caredx Inc   25.74 %
Medpace Holdings Inc   24.47 %
Acadia Pharmaceuticals Inc   21.60 %
Standard Biotools Inc   21.56 %
Eli Lilly And Company  21.24 %
Iradimed Corporation  20.89 %
Resmed Inc   18.67 %
Alector Inc   18.37 %
Corcept Therapeutics Inc  18.09 %
Chemed Corporation  17.73 %
Halozyme Therapeutics Inc   17.26 %
Pro dex Inc   16.75 %
Denali Therapeutics Inc   16.42 %
Krystal Biotech Inc   15.48 %
West Pharmaceutical Services Inc   15.47 %
Dexcom Inc   15.47 %
Intuitive Surgical Inc   14.71 %
Vertex Pharmaceuticals Inc  14.16 %
Neurocrine Biosciences Inc   13.69 %
Illumina Inc   13.43 %
Healthcare Services Group Inc   12.79 %
Kiniksa Pharmaceuticals International Plc  12.64 %
Tenet Healthcare Corp  12.39 %
Hca Healthcare Inc   11.73 %
Carlisle Companies Incorporated  11.72 %
Regeneron Pharmaceuticals Inc   11.50 %

Date modified: 2026-11-06T13:04:07+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.